Apple And J&J Collaborate On Large Atrial Fibrillation Study
Executive Summary
The Heartline Study is evaluating how the Apple Watch can identify and predict atrial fibrillation while improving cardiovascular outcomes and patients’ adherence to anticoagulant drugs.
You may also be interested in...
Cardio Conversations: 'Trials, Trials, Trials!' Volta Has Big Ambitions For AI In EP
In this edition of Cardio Conversations, Medtech Insight editor Reed Miller talked to Théophile Mohr Durdez, the CEO and co-founder of Volta Medical, a Marseille-based company applying artificial intelligence to electrophysiology. Volta has raised over €70m and is sponsoring the TAILORED AF trial to show that its software can make atrial fibrillation ablation more effective.
Apple Series 6 Watch Pumps Mobile Access To Blood Oxygen Saturation Measurement
The company is sponsoring research on how the blood oxygen sensor feature on its Apple Watch 6 could be applied to specific health problems.
Apple Adds Blood Oxygen Sensor To Apple Watch
The company is sponsoring research on how the blood oxygen sensor feature on its Apple Watch 6 could be applied to specific health problems.